Geistlich Pharma AG Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125

04:50 EDT 29 Sep 2018 | BioPortfolio Reports

Geistlich Pharma AG Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.


This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Scope


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Highlights


Geistlich Pharma AG Geistlich Pharma, a part of Geistlich Holding, develops, manufactures and markets biomaterials for the regeneration of bone, cartilage and tissue. The company offers dental products, including bone substitutes, matrices and membranes in various therapeutic areas such as extraction socket management, bone augmentation, sinus floor elevation, softtissue regeneration, periimplantitis and periodontal treatment. Its major products include Geistlich BioOss, a natural bone substitute; and Geistlich BioGide, a collagen membrane for oral tissue regeneration. The company also offers dietary supplements, infectiology and dermatology products. The company markets products through distribution partners and affiliates in UK, Germany, Italy, France, India, China, Brazil, South Korea, North America and Australia. Geistlich Pharma is headquartered in Wolhusen, Switzerland.


Geistlich Pharma AG Key Recent Developments


Mar 29,2018: Geistlich: Investment In Wolhusen Site

Nov 29,2017: Geistlich BioOss Collagen+Geistlich BioGide Received Clinical Research Award

Apr 24,2017: Geistlich Pharma posts excellent 2016 results


Reasons to Buy


Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.


Note: Some sections may be missing if data is unavailable for the company.

More From BioPortfolio on "Geistlich Pharma AG Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125"